^
Association details:
Biomarker:No biomarker
Cancer:Gastric Cancer
Drug:irinotecan (Topoisomerase I inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
…single agent docetaxel, paclitaxel and irinotecan are all recommended as preferred second-line treatment options for advanced gastric cancer.